AC Immune
ACIU
ACIU
64 hedge funds and large institutions have $118M invested in AC Immune in 2021 Q3 according to their latest regulatory filings, with 15 funds opening new positions, 21 increasing their positions, 18 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
0.73% less ownership
Funds ownership: 25.04% → 24.31% (-0.73%)
18% less capital invested
Capital invested by funds: $144M → $118M (-$26.2M)
Holders
64
Holding in Top 10
–
Calls
$1.82M
Puts
$976K
Top Buyers
| 1 | +$6.46M | |
| 2 | +$4.26M | |
| 3 | +$3.17M | |
| 4 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$2.66M |
| 5 |
Morgan Stanley
New York
|
+$1.93M |
Top Sellers
| 1 | -$12.7M | |
| 2 | -$10.8M | |
| 3 | -$1.56M | |
| 4 |
Point72 Asset Management
Stamford,
Connecticut
|
-$997K |
| 5 |
Two Sigma Investments
New York
|
-$901K |